Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma
Glioma is the most common intracranial malignant tumor, and its specific pathogenesis has been unclear, which has always been an unresolved clinical problem due to the limited therapeutic window of glioma. As we all know, surgical resection, chemotherapy, and radiotherapy are the main treatment meth...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-03-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.633827/full |
| _version_ | 1818863495712604160 |
|---|---|
| author | Yandong Xie Yandong Xie Yandong Xie Yuhan Han Yuhan Han Yuhan Han Xuefeng Zhang Hongwei Ma Linfeng Li Rutong Yu Rutong Yu Hongmei Liu Hongmei Liu |
| author_facet | Yandong Xie Yandong Xie Yandong Xie Yuhan Han Yuhan Han Yuhan Han Xuefeng Zhang Hongwei Ma Linfeng Li Rutong Yu Rutong Yu Hongmei Liu Hongmei Liu |
| author_sort | Yandong Xie |
| collection | DOAJ |
| description | Glioma is the most common intracranial malignant tumor, and its specific pathogenesis has been unclear, which has always been an unresolved clinical problem due to the limited therapeutic window of glioma. As we all know, surgical resection, chemotherapy, and radiotherapy are the main treatment methods for glioma. With the development of clinical trials and traditional treatment techniques, radiotherapy for glioma has increasingly exposed defects in the treatment effect. In order to improve the bottleneck of radiotherapy for glioma, people have done a lot of work; among this, nano-radiosensitizers have offered a novel and potential treatment method. Compared with conventional radiotherapy, nanotechnology can overcome the blood–brain barrier and improve the sensitivity of glioma to radiotherapy. This paper focuses on the research progress of nano-radiosensitizers in radiotherapy for glioma. |
| first_indexed | 2024-12-19T10:16:40Z |
| format | Article |
| id | doaj.art-07ac78f9297d4529baa3bab28836bfec |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-19T10:16:40Z |
| publishDate | 2021-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-07ac78f9297d4529baa3bab28836bfec2022-12-21T20:26:12ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.633827633827Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of GliomaYandong Xie0Yandong Xie1Yandong Xie2Yuhan Han3Yuhan Han4Yuhan Han5Xuefeng Zhang6Hongwei Ma7Linfeng Li8Rutong Yu9Rutong Yu10Hongmei Liu11Hongmei Liu12Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, ChinaDepartment of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaDepartment of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, ChinaInstitute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, ChinaDepartment of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaDepartment of Neurosurgery, Suqian First People’s Hospital, Suqian, ChinaInstitute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, ChinaInstitute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, ChinaInstitute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, ChinaInstitute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, ChinaDepartment of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaInstitute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, ChinaDepartment of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaGlioma is the most common intracranial malignant tumor, and its specific pathogenesis has been unclear, which has always been an unresolved clinical problem due to the limited therapeutic window of glioma. As we all know, surgical resection, chemotherapy, and radiotherapy are the main treatment methods for glioma. With the development of clinical trials and traditional treatment techniques, radiotherapy for glioma has increasingly exposed defects in the treatment effect. In order to improve the bottleneck of radiotherapy for glioma, people have done a lot of work; among this, nano-radiosensitizers have offered a novel and potential treatment method. Compared with conventional radiotherapy, nanotechnology can overcome the blood–brain barrier and improve the sensitivity of glioma to radiotherapy. This paper focuses on the research progress of nano-radiosensitizers in radiotherapy for glioma.https://www.frontiersin.org/articles/10.3389/fonc.2021.633827/fullnano-radiosensitizerradiotherapyradiation sensitizationnanoparticlesglioma |
| spellingShingle | Yandong Xie Yandong Xie Yandong Xie Yuhan Han Yuhan Han Yuhan Han Xuefeng Zhang Hongwei Ma Linfeng Li Rutong Yu Rutong Yu Hongmei Liu Hongmei Liu Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma Frontiers in Oncology nano-radiosensitizer radiotherapy radiation sensitization nanoparticles glioma |
| title | Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma |
| title_full | Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma |
| title_fullStr | Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma |
| title_full_unstemmed | Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma |
| title_short | Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma |
| title_sort | application of new radiosensitizer based on nano biotechnology in the treatment of glioma |
| topic | nano-radiosensitizer radiotherapy radiation sensitization nanoparticles glioma |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2021.633827/full |
| work_keys_str_mv | AT yandongxie applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT yandongxie applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT yandongxie applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT yuhanhan applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT yuhanhan applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT yuhanhan applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT xuefengzhang applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT hongweima applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT linfengli applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT rutongyu applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT rutongyu applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT hongmeiliu applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma AT hongmeiliu applicationofnewradiosensitizerbasedonnanobiotechnologyinthetreatmentofglioma |